QS Investors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $6.41M | Hold |
35,716
| – | – | 0.08% | 196 |
|
|
2021
Q1 | $5.97M | Sell |
35,716
-197
| -0.5% | -$32.8K | 0.07% | 211 |
|
|
2020
Q4 | $5.45M | Sell |
35,913
-69
| -0.2% | -$9.05K | 0.07% | 213 |
|
|
2020
Q3 | $3.63M | Buy |
35,982
+17,900
| +99% | +$1.96M | 0.05% | 257 |
|
|
2020
Q2 | $2.19M | Buy |
18,082
+15,665
| +648% | +$1.76M | 0.03% | 456 |
|
|
2020
Q1 | $230K | Hold |
2,417
| – | – | ﹤0.01% | 1025 |
|
|
2019
Q4 | $212K | Buy |
2,417
+270
| +13% | +$23.8K | ﹤0.01% | 1173 |
|
|
2019
Q3 | $172K | Sell |
2,147
-808
| -27% | -$65.1K | ﹤0.01% | 1239 |
|
|
2019
Q2 | $231K | Sell |
2,955
-35,400
| -92% | -$3.31M | ﹤0.01% | 1182 |
|
|
2019
Q1 | $4.5M | Sell |
38,355
-5
| -0% | -$583 | 0.05% | 299 |
|
|
2018
Q4 | $4.18M | Buy |
38,360
+3,467
| +10% | +$402K | 0.05% | 276 |
|
|
2018
Q3 | $4.46M | Buy |
34,893
+30,658
| +724% | +$3.79M | 0.04% | 318 |
|
|
2018
Q2 | $479K | Hold |
4,235
| – | – | ﹤0.01% | 958 |
|
|
2018
Q1 | $476K | Buy |
4,235
+215
| +5% | +$27.3K | ﹤0.01% | 943 |
|
|
2017
Q4 | $595K | Hold |
4,020
| – | – | 0.01% | 904 |
|
|
2017
Q3 | $471K | Hold |
4,020
| – | – | ﹤0.01% | 974 |
|
|
2017
Q2 | $522K | Sell |
4,020
-13,104
| -77% | -$1.63M | ﹤0.01% | 921 |
|
|
2017
Q1 | $2.32M | Sell |
17,124
-74,100
| -81% | -$11.2M | 0.02% | 552 |
|
|
2016
Q4 | $13.1M | Buy |
91,224
+31,980
| +54% | +$4.08M | 0.11% | 140 |
|
|
2016
Q3 | $7M | Buy |
59,244
+19,700
| +50% | +$2.37M | 0.05% | 278 |
|
|
2016
Q2 | $4.19M | Buy |
39,544
+26,500
| +203% | +$2.96M | 0.04% | 440 |
|
|
2016
Q1 | $1.45M | Buy |
13,044
+2,093
| +19% | +$265K | 0.01% | 697 |
|
|
2015
Q4 | $1.72M | Sell |
10,951
-1,261
| -10% | -$184K | 0.02% | 695 |
|
|
2015
Q3 | $1.6M | Sell |
12,212
-8,600
| -41% | -$1.38M | 0.02% | 677 |
|
|
2015
Q2 | $3.62M | Sell |
20,812
-7,854
| -27% | -$1.41M | 0.04% | 465 |
|
|
2015
Q1 | $4.94M | Hold |
28,666
| – | – | 0.06% | 379 |
|
|
2014
Q4 | $3.71M | Buy |
28,666
+15,166
| +112% | +$1.95M | 0.04% | 435 |
|
|
2014
Q3 | $1.74M | Sell |
13,500
-81,500
| -86% | -$8.4M | 0.05% | 259 |
|
|
2014
Q2 | $8.41M | Buy |
95,000
+53,400
| +128% | +$5.14M | 0.23% | 116 |
|
|
2014
Q1 | $3.91M | Buy |
41,600
+38,300
| +1,161% | +$3.92M | 0.12% | 173 |
|
|
2013
Q4 | $373K | Sell |
3,300
-1,300
| -28% | -$117K | 0.01% | 469 |
|
|
2013
Q3 | $363K | Sell |
4,600
-41,800
| -90% | -$3.06M | 0.02% | 473 |
|
|
2013
Q2 | $3.05M | Buy |
+46,400
| New | +$2.99M | 0.11% | 234 |
|
Other funds holding UTHR
ACA
PAI
QS Investors's UTHR Position: Q2 2021 in Review
QS Investors held its United Therapeutics (UTHR) position steady in Q2 2021 at 35,716 shares worth $6.41M. The position accounts for 0.08% of the portfolio, ranked #196.
QS Investors first reported a position in UTHR in Q2 2013 and has held it in 33 quarters since. The position peaked at $13.1M in Q4 2016. 403 funds tracked by Wall St. Rank hold UTHR as of Q2 2021.
- QS Investors held 35,716 shares of United Therapeutics worth $6.41M as of Q2 2021.
- QS Investors left its United Therapeutics share count unchanged in Q2 2021.
- United Therapeutics made up 0.08% of QS Investors's portfolio in Q2 2021, its #196 holding.
- QS Investors first reported a position in United Therapeutics in Q2 2013 and has held it in 33 quarters since.
- QS Investors's United Therapeutics position peaked at $13.1M in Q4 2016.
- 403 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.